Author

Olivia Barbara Farag

University of MiamiORCID 0009-0002-5457-5056Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Abdessamad Youssfi AlaouiiD· 2 shared Daniel BilbaoiD· 2 shared Dhanvantri ChahariD· 2 shared Francesco MauraiD· 2 shared Jonathan Harry SchatziD· 2 shared Paola ManaraiD· 2 shared Alexa Marie BarrosoiD· 1 shared Alexandra Marie CarboneiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Abdessamad Youssfi AlaouiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyLeukemiaPeer-reviewedNov 2, 2026

The cyclin-G associated kinase (GAK) is a novel mitotic kinase and therapeutic target in diffuse large B-cell lymphoma

Olivia Barbara Farag, Bassel Awada, Abdessamad Youssfi Alaoui…·Jonathan Harry Schatz

This paper identifies GAK as a novel mitotic kinase and therapeutic target in DLBCL, showing that GAK inhibition causes mitotic defects and that existing drugs can be repurposed for its targeting.

DOI 10.1038/s41375-026-03174-z

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCancer ResearchPeer-reviewedJul 31, 2025

NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapy

Paola Manara, Austin Daniel Newsam, Venu Venkatarame Gowda Saralamma…·Jonathan Harry Schatz

This study shows that inhibiting cap-dependent translation in lymphoma cells increases sensitivity to ferroptosis and CAR-T therapy by reducing NRF2 expression.

13 citations

humanbulk RNA-seq

𝕏 PostBluesky